Samosas, Jalebis Join Cigarettes On Health Alert List - Govt To Launch Food Warning Campaign
In a first-of-its-kind move, the Ministry of Health has ordered central government institutions, including AIIMS Nagpur, to install eye-catching "Oil and Sugar Boards" that expose the hidden fat and sugar content in everyday Indian snacks. These vivid, educational posters will soon be mandatory in cafeterias and common areas of public institutions, quietly but firmly reminding people of the dangers of excessive sugar and trans fat consumption.
Think of it as the beginning of cigarette-style food labeling.
The effort isn't to ban food, but to inform. A laddoo containing five teaspoons of sugar? A gulab jamun nearly the same? The government wants you to know, before you grab that second helping. 'Sugar and trans fats are the new tobacco,' says Amar Amale of the Cardiological Society of India. 'People deserve to know what they're putting into their bodies.'
Obesity Crisis at the Doorstep
India is staring down a major health crisis. Projections suggest over 44.9 crore Indians could be overweight or obese by 2050, placing the nation second only to the United States in the obesity index. With one in five urban adults already overweight and a surge in childhood obesity due to poor diets and inactivity, the situation is dire.
These new visual nudges in Nagpur and beyond are part of the larger war on non-communicable diseases like diabetes, hypertension, and cardiovascular disease, all of which are increasingly tied to India's love affair with oily, sugary treats.
Not a Ban, But a Wake-Up Call
Government sources clarify that this isn't a crackdown on traditional food. The initiative is part of a broader public awareness movement that ties into Prime Minister Modi's 'Fit India' campaign, which promotes healthier food choices and encourages a 10% cut in oil consumption.
These signboards are intended to be bold yet non-intrusive, nudging Indians toward wiser eating habits. Picture this: you're eyeing a crispy pakora or a sugary jalebi, and next to it, a sign gently says, 'Eat wisely. Your future self will thank you.' Because while traditions are sacred, your health is, too.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mint
43 minutes ago
- Mint
Sacrifices, trade-offs behind big win, says Glenmark's Saldanha
The road to drug discovery is long, arduous and littered with failure, but the payoff at the end makes it worth the trouble. It's a lesson that India's best pharmaceutical entrepreneurs knew all along. Yet, it took a Glenn Saldanha to prove it. 'We were always resilient in how we approached innovation. I think that's what finally rewarded us," Saldanha, chief executive officer and managing director of Glenmark Pharmaceuticals Ltd, told Mint in an exclusive interview. He was referring to one of the largest deals for an Indian biopharma firm after Glenmark's US-based unit Ichnos Glenmark Innovation (IGI) secured a $700-million exclusive licensing agreement with AbbVie for its blood cancer drug candidate last week. AbbVie will also pay as much as $1.23 billion as various milestones are completed, as well as tiered, double-digit royalties on net sales. ISB 2001, the investigational drug to treat multiple myeloma, is in phase-1 clinical trials and has shown promising data. In a trial with 35 patients who had exhausted all existing lines of therapy unsuccessfully, 79% showed a clinical response to it, and 30% were cancer-free. 'I hope this acts as a catalyst to expanding the innovation landscape in India…we've demonstrated that you can do it," said Saldanha. Last bet ISB 2001, developed on IGI's proprietary BEAT platform, was the firm's last bet. 'There was no plan B," said Saldanha. 'This was pretty much the end of the road. At this point, the technology had to demonstrate that it worked…or we don't know what we would have done as the next thing." The drug had been in discovery over the last five years, while the company had been working on the BEAT platform for about a decade. There were three other assets that the company stopped developing. ISB 2001 has received both the US FDA Orphan Drug and Fast Track designations, highlighting its Orphan Drug designation is given to drugs treating rare diseases, while a fast track designation intends to expedite the development and review of drugs for treating serious conditions and fill unmet medical needs. Following the licensing agreement, AbbVie will take over further development for phase-2 and phase-3 trials before it can file for regulatory approval. The process would typically take four to five years. The market size for multiple myeloma is estimated to grow to $50 billion by 2030. Should the drug hit the markets in 2030, taking into account the tiered double-digit royalties, Glenmark stands to earn an additional $2.02 billion in royalties until 2041, according to research by brokerage Nuvama. The deal validates several aspects of Glenmark, including the strength of IGI's BEAT platform, the potential for ISB 2001 to treat relapsed/refractory multiple myeloma, and its commercial viability following successful clinical trials, said an 11 July note by Motilal Oswal analysts. 'Moreover, AbbVie has established itself as a diversified biopharma leader, combining scientific innovation with strong commercial execution. In oncology, the company has built a robust presence anchored by two cornerstone therapies: Imbruvica, a BTK inhibitor, and Venclexta, a BCL-2 inhibitor. These medicines have transformed the treatment landscape for chronic lymphocytic leukemia and other B-cell malignancies, generating multi-billion-dollar revenues and reinforcing AbbVie's reputation as a pioneer in hematologic cancer," the note added. Huge sacrifices, trade-offs Saldanha has bet on innovation since he took the reins of the company in the late 90s. A few years after Glenmark was listed in 2000, it established its first R&D centre for novel biologics research in Switzerland. Over the years, the company did a number of licensing deals with novel assets. In 2019, it spun off its R&D entity under a new company, Ichnos Sciences, which built on its proprietary BEAT bispecific platform. The two announced the creation of Ichnos Glenmark Innovation (IGI) in 2024. The company's focus on innovation created a lot of frustration for investors and stakeholders, Saldanha said. '[We were] bordering on being called eccentric," he said. The company also had to sell its stake in its active pharmaceutical ingredient (API) division, Glenmark Life Sciences, to pare its debt in 2023, which was approximately ₹4,500-4,600 crore. Glenmark sold 75% stake in the unit to industrial conglomerate Nirma for ₹5,650 crore. The company has made 'huge sacrifices, huge trade-offs," said Saldanha. With the GLS sale, the company had a choice to decide 'which end of the value chain we play", said Saldanha. 'Whether we play on this API stable end of the value chain, and generate revenues like that, or we play on the high end of the value chain, which is innovation." But innovation is not a cost game, he said. 'It's all about being able to understand where the therapy is going and how to come up with solutions." What's next for Glenmark? IGI spends about $70 million annually on new drug research. With the upfront payment it receives, it will be self-funded for the next three to four years, said Saldanha. The company will also look at rewarding shareholders with dividends. Apart from that, there are no immediate investment plans, said Saldanha. 'At least for the next year or two, we won't do anything. We'll just continue regrouping and trying to figure out strategically where we can further add value," he said. The deal is a big event for the company, which 'basically resets the whole agenda for the company", he said. 'We have to really reset and rethink how we want to see the company over the next five to ten years." ISB 2001's early success has validated the BEAT platform. 'We think we've now got it right with the technology…the idea is how can we exploit that technology much more effectively to add more products and do more," said Saldanha. The unit has another asset called ISB 2301, which is in late pre-clinical development and will go to the clinic next year. This drug will target solid tumours, said Saldanha. IGI also has a couple of other early-stage programs. '...over the next three, four years, we will exploit the technology as effectively as possible."
NDTV
an hour ago
- NDTV
Samosa, Jalebi And Other Indian Snacks To Carry Health Warnings: "A Big Step To Tackle India's Obesity Crisis," Says Expert
After cigarettes, delicious Indian snacks like samosa, vadapav, kachori and jalebi will soon carry health warnings. As an initiative to promote healthy eating and lifestyle to combat obesity and non-communicable diseases, the Union Health Ministry has urged all ministries, departments and autonomous bodies to display warnings on Indian snacks. The ministry has urged to display oil and sugar content of these food items. It has also called for printing health messages on all official stationeries such as letterheads, envelopes, notepads, folders, etc and publications to reinforce daily reminders on fighting obesity. Are samosas, jalebis and vadapavs harmful? Obesity is a serious yet preventable health condition. This lifestyle disorder can be reversed and prevented with proactive measures that majorly focus on diet and lifestyle interventions. "Foods like jalebis have a very high glycemic index and can spike up your blood sugars without providing any nutritional value. Not just obesity, heavy consumption of these foods can increase the risk of serious health conditions like diabetes, high blood pressure, high cholesterol and much more," Dr. Sameer Gupta, Senior Cardiologist, Group Cardiac Cath Lab Director at Metro Hospitals. "Additionally, foods like samosas and vadapavs are high in trans fat, which can cause inflammation and lead to arterial blockage by contributing to plaque buildup in arteries," Dr. Gupta added. Will these warnings actually help? "The tsunami of obesity, diabetes and high blood pressure in this country mainly because of poor eating habits needs to be controlled with such health policies." "This initiative will empower the common people about the nutritional value of food and help them make conscious food choices," Dr. Gupta highlighted. How will this be put into effect? The information posters will mention fat and sugar content in popular foods. This clear information about sugar and trans fat content will function like health warning labels on cigarettes. "Oil and Sugar Board" in schools, offices, public institutions, autonomous bodies and other organisations displaying key information about hidden fats and sugars in everyday foods can help raise awareness on harmful consumption. Health messages that outline long-term health risks from frequent consumption of these foods will also be implemented. This initiative has also urged organisations and institutions to promote the availability of healthier food options and limit accessibility of sugary drinks and high-fat snacks. It also highlights the role of physical activity. India's obesity burden A sharp rise in obesity rates in India over the past few years is now a significant public health concern. Obesity has serious health implications, fueling non-communicable diseases such as diabetes, heart disease, mobility, quality of life and certain cancers. According to the National Family Health Survey NFHS-5 (2019-21), more than one in five adults in urban areas are overweight or obese. While 24% of Indian women and 23% of Indian men are overweight or obese, a significant increase in the percentage of children under 5 years who are overweight has also been observed from 2.1% to 3.4 %. A Lancet study published in 2025 also revealed that about 450 million adults in India are expected to be overweight or obese in 2050. Addressing these challenges requires a multi-faceted approach, including better public health policies, promoting physical activity, improving access to healthy foods, and increasing awareness about nutritional intake and healthy lifestyles. In the 119th Episode of Mann Ki Baat, Prime Minister Narendra Modi also urged the country to draw focus on the obesity epidemic and mentioned that obesity cases have doubled in the last few years and there is an urgent need to focus on the prevalence of obesity in India. He urged people to reduce their cooking oil consumption by 10 per cent. Advocating the same, Dr. Sameer Gupta who is also the Co-Chair of the Healthcare community at PHD Chamber of Commerce adds, "India is the diabetes capital of the world. Furthermore, an alarming increase in obesity and hypertensive individuals triggers the disease burden of the country. These food labels will empower people to make the right food choices. It is a very good and much-needed step towards a fitter India." "You cannot be a wealthy nation if you are not a healthy nation," he concluded.
India Gazette
an hour ago
- India Gazette
Regulate western Pizzas, donuts too along with desi samosas, jalebi: Rajya Sabha MP Milind Deora on Govt's eat healthy drive
Mumbai (Maharashtra) [India], July 14 (ANI): Shiv Sena MP Milind Deora and chair of Parliamentary Committee on Subordinate Legislation on Monday said India should regulate unhealthy foods sold by multinational companies, along with Indian snacks such as jalebis and samosas, to deal with rising obesity problems. The Union health ministry has recently proposed displaying sugar and oil boards as an initiative to promote healthier dietary habits in various settings. According to the ministry's proposal, these boards will serve as visual behavioural nudges in schools, offices, public institutions etc. displaying key information about hidden fats and sugars in everyday foods. 'Placing greater stringent regulations on unhealthy foods like jalebi, like samosa, this is a welcome step,' Deora told ANI. 'As chairman of the Parliament Subordinate Legislation Committee, which has members of parliament from all parties, we are at present examining this very issue. Along with the agency called the FSSAI which is the food regulator in our country,' the Rajya Sabha MP said. 'And we are examining how the food regulator can be more stringent to ensure that the average consumer in India makes more informed choice when buying product for the family members.' 'One of our recommendations in the last few meetings that we had with members of the Ministry of Health has been that while you want to regulate and you want to curb the consumption, or you want to make consumers aware of the unhealthy ingredients associated with foods like samosa and jalebi. We should also do that with western foods that are coming in market. We should also do that with burgers with pizzas, with donuts with other products that are being imported from the West,' he said. 'Otherwise there will not be a level playing field, the small shopkeeper on the streets whose jalebi and samosa sales will be adversely affected. But large multinational chain like should be a level playing field where consumers are aware of these harmful side effects,' the Rajya Sabha MP said '...The state and central governments have imposed hefty taxes on cigarettes, yet people smoke. The government can only bring regulations to disincentivise people... The processed packaged juices are not fruit juices. They are sugar drinks. There is no difference between that drink and Coca-Cola. Some studies say that Coca-Cola is healthier than those drinks... I am confident that under the leadership of PM Modi and our dynamic Health Minister JP Nadda, soon Indian and Western junk food will be controlled in India's food sector...' Deora said. Departments/Offices/autonomous bodies and other public institutions/organizations under the Ministry have been asked to install oil and sugar board displays (Digital/ Static posters) in common areas (cafeterias, lobbies, meeting rooms and other public spaces) to raise awareness on harmful consumption. They are also asked to print health messages on all official stationery (letterheads, envelopes, notepads, folders, etc.) and publications to reinforce daily reminders on fighting obesity. Besides, they were asked to promote healthy meals and physical activity in offices through nutritious, healthier food options (more fruits, vegetables, and low-fat options, and by limiting availability of sugary drinks and high-fat snacks) and active workplace initiatives (such as encouraging use of stairs, organizing short exercise breaks, and facilitating walking routes). India is witnessing a sharp rise in obesity among both adults and children. As per NFHS-5 (2019-21) data, over one in five adults in urban areas are overweight or obese. Prevalence of childhood obesity is impacted by poor dietary habits and reduced physical activity. As per the Lancet GBD 2021 obesity forecasting study, published in 2025, the number of overweight and obese adults in India is projected to rise from 18 crores in 2021 to 44.9 crores by 2050, making it the country with the second-highest global burden. Obesity significantly raises the risk of Non-Communicable Diseases such as diabetes, hypertension, heart disease, and certain cancers. It also affects mental health, mobility, and quality of life, and imposes a heavy economic burden through increased healthcare costs and productivity losses. Early prevention and health promotion are critical to reversing these trends. Prime Minister Narendra Modi at the Opening Ceremony of the 38th National Games in Dehradun on January 28, 2025, PM Modi invoked the Fit India Campaign and urged citizens to adopt active, healthy lifestyles as part of the broader vision of a Swasth Bharat. In one of his Mann Ki Baat radio programme episodes, he called for a 10 per cent reduction in oil consumption. Against this backdrop, the Union health ministry has proposed displaying Sugar and Oil Boards as an initiative to promote healthier dietary habits in various settings. These boards serve as visual behavioural nudges in schools, offices, public institutions, etc., displaying key information about hidden fats and sugars in everyday foods. The move is part of the Union Health ministry's flagship initiatives under National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) to promote sustainable behavioural changes in workplaces. These include reducing excessive consumption of oil and sugar, both of which are key contributors to rising rates of obesity, diabetes, hypertension, and other lifestyle-related disorders. (ANI)
